Pilot Study of Raptiva to Treat Sjogren's Syndrome

NCT00344448 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

NIH

Sponsor class

Stopped Increased risk of PML associated with raptiva in other studies

Conditions

Sjogren's Syndrome

Interventions

DRUG: Raptiva

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)